{
  "question_stem": {
    "en": "A 23-year-old man comes to the clinic for a follow-up appointment. Laboratory results from his wellness visit 6 weeks ago included a hemoglobin level of 12.3 g/dL, suggesting mild anemia. The patient has otherwise been well. He feels that his energy level is normal, and he has run several half-marathons in the past 2 years. Today's laboratory results are as follows:\n\nHemoglobin\t12.2 g/dL\nErythrocytes\t5.8 million/mm³\nMean corpuscular volume\t74 µm³\nLeukocytes\t6,500/mm³\nPlatelets\t180,000/mm³\nHemoglobin A₂\t6% (normal: 1%-3%)\n\nThe patient's blood smear is shown below {{exhibit_1}}.",
    "zh": "一名23岁的男性前来诊所复诊。6周前健康体检的实验室结果显示血红蛋白水平为12.3 g/dL，提示轻度贫血。患者其他方面情况良好。他感觉精力正常，并且在过去2年里跑了几个半程马拉松。今天的实验室结果如下：\n\n血红蛋白\t12.2 g/dL\n红细胞\t5.8 million/mm³\n平均红细胞体积\t74 µm³\n白细胞\t6,500/mm³\n血小板\t180,000/mm³\n血红蛋白A₂\t6% (正常值: 1%-3%)\n\n患者的血涂片如下所示 {{exhibit_1}}。"
  },
  "question": {
    "en": "Which of the following is the most likely initial pathologic defect leading to this patient's current condition?",
    "zh": "以下哪项最可能是导致该患者目前病情的最初病理缺陷？"
  },
  "options": {
    "A": {
      "en": "Cell membrane instability",
      "zh": "细胞膜不稳定"
    },
    "B": {
      "en": "Complete gene deletion",
      "zh": "基因完全缺失"
    },
    "C": {
      "en": "Elevated oxidative stress",
      "zh": "氧化应激升高"
    },
    "D": {
      "en": "Erroneous mRNA processing",
      "zh": "mRNA处理错误"
    },
    "E": {
      "en": "Impaired heme synthesis",
      "zh": "血红素合成受损"
    },
    "F": {
      "en": "Insoluble protein formation",
      "zh": "不溶性蛋白形成"
    }
  },
  "correct_answer": "D",
  "explanation": {
    "en": "This patient has a mild microcytic (mean corpuscular volume <80 µm³) anemia and an elevated hemoglobin (Hb) A₂ (alpha-2 delta-2) concentration. These findings, in addition to peripheral smear revealing poikilocytes (spherocytes and target cells) {{exhibit_2}}, suggest beta-thalassemia trait.\n\nPatients with beta-thalassemia trait have 1 normal beta-globin allele and 1 mutated beta-globin allele. Most mutations are point mutations leading to faulty mRNA processing (eg, splicing error) or premature translation termination. Decreased production of normal beta-globin chains results in limited formation of normal adult hemoglobin (Hb A) and increased production of hemoglobin subtypes (eg, Hb A₂) from pairing of excess alpha-globin chains with non-beta-globin chains. The imbalance in the ratio of alpha-/beta-globin chains also results in unpaired excess alpha-globin chains, which are insoluble (precipitating adjacent to the red blood cell [RBC] membrane) and susceptible to oxidation. This causes cell membrane instability and destruction of some early RBC precursors within the bone marrow (ineffective erythropoiesis).\n\nBecause patients with beta-thalassemia trait have 1 normal beta-globin allele, their anemia is usually mild and often discovered on routine laboratory evaluation. Peripheral smear may reveal target cells, which are formed when reduced cell volume from decreased hemoglobin allows a relative excess of membrane to sink in. Spherocytes may also be present and are due to cell membrane damage and injury to cytoskeletal components in more mature RBCs. Because hemoglobin levels are low, the marrow attempts to compensate by increasing erythrocyte production, resulting in a normal to slightly high erythrocyte count, as seen in this patient.\n\n(Choices A, C, and F) Although insoluble protein (ie, alpha-globin chain) formation, elevated oxidative stress, and cell membrane instability occur in beta-thalassemia, a genetic mutation affecting the transcription, processing, or translation of beta-globin mRNA is the initial pathologic defect.\n\n(Choice B) Complete gene deletion is the most common mechanism causing alpha-thalassemia, which is associated with decreased (not elevated) hemoglobin A₂ due to impaired alpha chain production. In contrast, most cases of beta-thalassemia occur due to point mutations.\n\n(Choice E) Hemoglobin contains 2 components, an iron-containing heme component and a globin component. Impaired heme synthesis results in porphyria. Thalassemias are due to disruption to the globin component.\n\nEducational objective:\nPatients with beta-thalassemia trait have 1 normal beta-globin allele and 1 mutated beta-globin allele. The gene mutation most commonly impairs mRNA processing (eg, splicing) or translation, resulting in reduced production of normal beta-globin chains. Patients are typically asymptomatic with laboratory findings of mild microcytic anemia, target cells, and increased hemoglobin A₂ concentration. {{exhibit_3}}",
    "zh": "该患者患有轻度小细胞性（平均红细胞体积<80 µm³）贫血和血红蛋白（Hb）A₂（alpha-2 delta-2）浓度升高。这些发现，以及外周血涂片显示异形红细胞（球形红细胞和靶形红细胞）{{exhibit_2}}，提示β-地中海贫血携带者。\n\nβ-地中海贫血携带者有1个正常的β-珠蛋白基因等位基因和1个突变的β-珠蛋白基因等位基因。大多数突变是点突变，导致mRNA处理错误（例如，剪接错误）或翻译过早终止。正常β-珠蛋白链的产生减少导致正常成人血红蛋白（Hb A）的形成受限，以及血红蛋白亚型（例如，Hb A₂）的产生增加，这是由于过量的α-珠蛋白链与非β-珠蛋白链配对所致。α-/β-珠蛋白链比例失衡也会导致未配对的过量α-珠蛋白链，这些α-珠蛋白链不溶（沉淀在红细胞[RBC]膜附近）并且易于氧化。这会导致细胞膜不稳定，并破坏骨髓内的一些早期红细胞前体（无效红细胞生成）。\n\n由于β-地中海贫血携带者有1个正常的β-珠蛋白基因等位基因，因此他们的贫血通常很轻微，并且通常在常规实验室评估中发现。外周血涂片可能显示靶形红细胞，当血红蛋白降低导致细胞体积减小，从而使相对过量的膜沉入其中时，就会形成靶形红细胞。也可能存在球形红细胞，这归因于细胞膜损伤和更成熟红细胞中细胞骨架成分的损伤。由于血红蛋白水平较低，骨髓试图通过增加红细胞生成来代偿，从而导致红细胞计数正常或略高，如该患者所见。\n\n（选项A、C和F）尽管在β-地中海贫血中会发生不溶性蛋白（即α-珠蛋白链）形成、氧化应激升高和细胞膜不稳定，但影响β-珠蛋白mRNA转录、加工或翻译的基因突变是最初的病理缺陷。\n\n（选项B）基因完全缺失是导致α-地中海贫血的最常见机制，由于α链产生受损，其与血红蛋白A₂降低（而非升高）有关。相比之下，大多数β-地中海贫血病例是由于点突变引起的。\n\n（选项E）血红蛋白包含2个成分，一个含铁的血红素成分和一个珠蛋白成分。血红素合成受损会导致卟啉病。地中海贫血是由于珠蛋白成分的破坏所致。\n\n教育目标：\nβ-地中海贫血携带者有1个正常的β-珠蛋白基因等位基因和1个突变的β-珠蛋白基因等位基因。基因突变最常损害mRNA处理（例如，剪接）或翻译，导致正常β-珠蛋白链的产生减少。患者通常无症状，实验室检查结果显示轻度小细胞性贫血、靶形红细胞和血红蛋白A₂浓度升高。{{exhibit_3}}"
  },
  "summary": {
    "en": "This question tests knowledge of beta-thalassemia trait, including its pathophysiology, laboratory findings (microcytic anemia, elevated HbA2), and peripheral smear characteristics (target cells, poikilocytes). It also tests the understanding of the underlying genetic defect in beta-thalassemia. \n\nTo solve this question, recognize the findings suggestive of beta-thalassemia trait. Then, recall that beta-thalassemia is most commonly caused by point mutations affecting mRNA processing, leading to reduced beta-globin chain production.",
    "zh": "此问题考察了对β-地中海贫血携带者的认识，包括其病理生理学、实验室检查结果（小细胞性贫血，HbA2升高）和外周血涂片特征（靶形细胞，异形红细胞）。它还考察了对β-地中海贫血潜在遗传缺陷的理解。\n\n为了解决这个问题，要认识到提示β-地中海贫血携带者的发现。然后，回想起β-地中海贫血最常由影响mRNA处理的点突变引起，导致β-珠蛋白链的产生减少。"
  },
  "tags": "Beta-thalassemia trait; Microcytic anemia; Hemoglobin A2; mRNA processing; Point mutation; Hematology; Genetics; Peripheral smear; Target cells; Poikilocytes",
  "category": "Blood",
  "question_id": "1940",
  "has_exhibits": true,
  "exhibit_count": 3,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg",
    "image3.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Blood 23\\1940",
  "extracted_at": "2025-11-05T11:31:14.222915",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:30:37.394962",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}